ANN NEUROL 润色咨询

ANNALS OF NEUROLOGY

出版年份：1977 年文章数：3715 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2024-06-03 blackxzw 来自上海

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向：临床
    经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2023-05-08 1251f664m27暂无昵称 来自山东省

    投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？

    10

    展开10条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2024-03-09 1229554913 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：审稿速度快

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2024-03-09 1229554913 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：审稿速度快

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2023-10-21 ms3000000820351175 来自荷兰

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向：血管病
    经验分享：投稿后马上变成under review，两天后变成evaluating recomendation

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2023-03-02 ms8000001884736215 来自北京

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：第二天就Under Review，不知道啥意思

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2023-11-11 147f4ce1m48(暂无昵称) 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：近几年要求较高，研究质量高可试试

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2022-05-27 12588598m48暂无昵称

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：neurology
    经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2022-12-09 ms1000000413306818 来自福建省

    一个月过去了，还是under review，有人同样情况的吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2208042, encodeId=216f2208042bd, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：临床<br>经验分享：本人在ANA投稿一篇research，经过两轮外送审稿，目前状态Evaluating Recommendations, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54755503821, createdName=blackxzw, createdTime=Mon Jun 03 12:27:26 CST 2024, time=2024-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：血管病<br>经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：neurology<br>经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=)]
    2022-06-01 ms6000000601742295

    投稿之后会给所有作者发邮件确认吗？

    1

    展开1条回复
共57条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分